Detalhe da pesquisa
1.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048793
2.
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.
Cancer
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470379
3.
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
Gynecol Oncol
; 184: 168-177, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325276
4.
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Cancer
; 129(12): 1846-1855, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060236
5.
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecol Oncol
; 170: 186-194, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706645
6.
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy.
J Natl Compr Canc Netw
; 21(5): 473-479.e4, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156482
7.
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Gynecol Oncol
; 165(1): 30-39, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123771
8.
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
N Engl J Med
; 375(22): 2154-2164, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717299
9.
Efficacy and safety of niraparib as maintenance treatment in older patients (≥â¯70â¯years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.
Gynecol Oncol
; 152(3): 560-567, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30638768
10.
Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.
Dis Colon Rectum
; 60(8): 785-791, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28682963
11.
Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.
Cancer
; 122(20): 3119-3126, 2016 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412268
12.
Effectiveness and Tolerability of Maintenance Capecitabine Administrated to Patients with Metastatic Pancreatic Cancer Treated with First-Line FOLFIRINOX.
Oncology
; 90(5): 261-6, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27097162
13.
Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy.
Dis Colon Rectum
; 56(10): 1125-33, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24022529
14.
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France.
Bull Cancer
; 110(10): 1041-1050, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659907
15.
[Practical management of PARP inhibitors: A French DELPHI consensus]. / Gestion pratique des inhibiteurs de PARP : Un consensus national DELPHI.
Bull Cancer
; 109(12): 1245-1261, 2022 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-36109248
16.
Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients.
Front Pharmacol
; 12: 711813, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34616296
17.
Allergy Evaluation of Hypersensitivity to Platinum Salts and Taxanes: A Six-Year Experience.
J Allergy Clin Immunol Pract
; 8(5): 1658-1664, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31918017
18.
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.
Clin Cancer Res
; 26(17): 4625-4632, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209570
19.
Primitive neuroectodermal tumor of the pelvis in an elderly patient.
Onkologie
; 32(8-9): 499-502, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19745594
20.
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.
J Clin Oncol
; 37(32): 2968-2973, 2019 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173551